Related Experiment Videos
Gastrointestinal blood loss on phenylbutazone and feprazone
Rheumatology and Rehabilitation
|May 1, 1976
Abstract:
Feprazone, a new anti-inflammatory drug, is a useful antirheumatic preparation which causes little gastrointestinal upset. This short cross-over study shows no significant gastrointestinal blood loss with either feprazone or phenylbutazone by the red-cell chromium-51 labelling method.